ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

Statin Drugs May Prevent Breast Cancer, Lab Suggests

April 25, 2003

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981